Affluent Medical completes its Management Committee

(Boursier.com) — Affluent Medical announced the appointments of Christophe de Vregille as Chief Financial Officer and Benjamin Renault as Chief Development Officer. Christophe de Vregille and Benjamin Renault will complete the existing ‘medtech’ management team to support the execution of the development plan and address the next steps leading to the commercialization of Affluent Medical’s three cutting-edge medical devices, which have the potential to change the lives of patients with structural heart disease and urological dysfunction. Sébastien Ladet, Chief Executive Officer comments: “I am delighted to welcome Christophe de Vregille and Benjamin Renault to Affluent Medical’s management team as we approach several decisive steps in the deployment of our development strategy. Christophe de Vregille’s experience will be a real asset to support the Company’s growth and financing. Benjamin Renault brings extensive experience in the development of medical devices which will enable us to strengthen our expansion with a view to marketing on international markets.” .